syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.52803179	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.16549693642173
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.44034283475214
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	1.0667311	69.81079235269051
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.037309752	67.88535152138425
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.00613497	65.84515954344117
YOU-HOOVER-FONG SYNDROME; YHFS	1.002119392	65.58236540353654
UROFACIAL SYNDROME	1.0	65.44366462428115
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	1.0	65.44366462428115
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	62.067596119842506
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.642857	42.07091790937151
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	41.811211270676516
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.19376923434296
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.5230362329999999	34.229407818799366
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.519711782	34.011843562495514
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	33.95661683190505
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.684240299738796
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.510787083	33.42777855426686
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.502119392	32.86053309139596
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.502119392	32.86053309139596
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.500915751	32.78176241346392
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.77705904273104
COMBINED SAPOSIN DEFICIENCY	0.5	32.72183231214058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.72183231214058
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.5	32.72183231214058
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.72183231214058
SCHIZOPHRENIA 10	0.5	32.72183231214058
OCULAR MOTOR APRAXIA	0.5	32.72183231214058
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.72183231214058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.49717729199999994	32.53710395645629
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.488691082	31.98173527528508
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.475717633	31.132705229908858
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.520889882794915
CENTRALOPATHIC EPILEPSY	0.4484126	29.34576380770193
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	29.34576380770193
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	29.34576380770193
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.030807768731044
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.030807768731044
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.38033377	24.890435689168484
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.559292709479557
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.559292709479557
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	23.727829772442103
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.64817292184739
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.536735449725164
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.35948283300000006	23.52587396103847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.354320292	23.188018359225364
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.35417387	23.17843596696375
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	22.89231705055037
ANGELMAN SYNDROME	0.33509263300000003	21.929689892119328
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.645477807762102
AICARDI SYNDROME; AIC	0.32627551	21.35266505155629
TUBEROUS SCLEROSIS	0.32591575100000003	21.329121104214725
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.317208182	20.759265878885934
SPINOCEREBELLAR ATAXIA 12	0.27777799999999997	18.178810272003567
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	17.438700146415147
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.378550874258973
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.323324143668504
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.252191261	16.504320306058553
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.250843882	16.416142886660758
DYSTONIA 6, TORSION	0.25	16.36091615607029
HYPERPARATHYROIDISM 2	0.25	16.36091615607029
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.36091615607029
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.36091615607029
HYPEREKPLEXIA 1; HKPX1	0.25	16.36091615607029
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.36091615607029
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.36091615607029
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.36091615607029
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.36091615607029
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.687397308664632
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.687397308664632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	13.143959655446697
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.143959655446697
DYSTONIA 16; DYT16	0.19821249	12.97175171990368
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	12.723169980645494
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.19127389	12.517664308541644
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.1883115	12.32379465089532
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.18214338200000002	11.920130405140329
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.864903674549861
TREMOR, HEREDITARY ESSENTIAL, 1	0.1704545	11.155167131699532
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.169702143	11.105930132513802
HUNTINGTON DISEASE-LIKE 2	0.166667	10.907299251935067
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.166667	10.907299251935067
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.166667	10.907299251935067
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.16589323299999997	10.856661103889728
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.16589323299999997	10.856661103889728
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.1641336	10.741504271975911
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.16256878199999997	10.639096847585872
SPINOCEREBELLAR ATAXIA 27; SCA27	0.1565655	10.24622007373289
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.15275798999999998	9.997042666239292
PELIZAEUS-MERZBACHER DISEASE	0.15202711299999996	9.94921139696969
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.14899196999999997	9.750580516390956
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.146374782	9.579302142660266
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.14589214299999997	9.547716477809665
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.14589214299999997	9.547716477809665
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.14504826099999998	9.492489747219198
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.14497639199999998	9.487786376486316
Pontine tegmental cap dysplasia	0.14461663299999997	9.464242429144749
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.14461663299999997	9.464242429144749
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.14377275099999998	9.409015698554281
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.404312327821398
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.14370088199999997	9.404312327821398
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.1436542	9.40125728666941
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.14285699999999998	9.349085597230932
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.14285699999999998	9.349085597230932
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14285699999999998	9.349085597230932
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.14285699999999998	9.349085597230932
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.14285699999999998	9.349085597230932
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.14285699999999998	9.349085597230932
BRUNNER SYNDROME; BRNRS	0.14285699999999998	9.349085597230932
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.14285699999999998	9.349085597230932
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.14285699999999998	9.349085597230932
CHROMOSOME 1P36 DELETION SYNDROME	0.135787083	8.886404320161429
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.13490099	8.828415147043504
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.79723189528668
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	8.785048444574574
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.13402745000000002	8.771247488247612
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.1333978	8.730040884816932
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.669891612660756
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.1323876	8.663929694813483
#602398 DESMOSTEROLOSIS	0.128035143	8.379088958613877
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.127119392	8.319158857290528
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.127119392	8.319158857290528
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.240388179358494
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.240388179358494
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	8.235684808625612
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.229141620149145
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.125	8.180458078035144
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.125	8.180458078035144
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.125	8.180458078035144
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.125	8.180458078035144
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.125	8.180458078035144
SPINAL MUSCULAR ATROPHY, TYPE IV	0.125	8.180458078035144
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.125	8.180458078035144
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.125	8.180458078035144
DYSTONIA 7, TORSION	0.125	8.180458078035144
SPINAL MUSCULAR ATROPHY, TYPE II	0.125	8.180458078035144
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.125	8.180458078035144
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.125	8.180458078035144
DYSTONIA 23; DYT23	0.12101198999999999	7.9194680890768625
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.11724596999999999	7.673005939228528
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.1121212	7.337622210071952
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.11111099999999999	7.271511020068503
#615034 DYSTONIA 24; DYT24	0.11111099999999999	7.271511020068503
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.11111099999999999	7.271511020068503
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.075029505767024
WHITE-SUTTON SYNDROME; WHSUS	0.102119392	6.683067241683499
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.604296563751467
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.5443664624281155
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.5443664624281155
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.5443664624281155
MYOCLONUS AND ATAXIA	0.0981997	6.426548233005021
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	6.324140808614984
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.095522192	6.251322297424192
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.09495077	6.213926347697256
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.87236152986058
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.08425997	5.514281217931991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.08271528200000001	5.413191174510841
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.079897192	5.228765037669799
LISSENCEPHALY 2; LIS2	0.079042492	5.172830337515426
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	5.161469840885967
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07819861	5.117603606924958
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07776698200000001	5.08935628885051
CANAVAN DISEASE	0.07692310000000001	5.034129558260042
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.034129558260042
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.034129558260042
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.07656769	5.010870225415925
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.07639647000000001	4.999664961158957
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	4.997178887227209
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.870546574165188
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.870546574165188
PARKINSON DISEASE, LATE-ONSET; PD	0.07280167	4.76440807556759
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.59817004199893
WAISMAN SYNDROME; WSMN	0.068426333	4.478069988321383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0667321	4.367193172073993
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0666667	4.362913156407563
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0666667	4.362913156407563
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0666667	4.362913156407563
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0666667	4.362913156407563
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0666667	4.362913156407563
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0666667	4.362913156407563
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.0666667	4.362913156407563
#607688 PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	0.0666667	4.362913156407563
#614203 PARKINSON DISEASE 17; PARK17	0.0666667	4.362913156407563
#614251 PARKINSON DISEASE 18; PARK18	0.0666667	4.362913156407563
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.064619392	4.228929818272956
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.199061853287751
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	4.138912581131575
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	4.138912581131575
MENTAL RETARDATION, X-LINKED 98; MRX98	0.062568333	4.094701000952343
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9193948968823484
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.056831110000000004	3.719236103065631
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.707167636872267
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.695692155724064
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.6909887849911818
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.055828989999999995	3.653653697872346
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.635762054400714
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.635762054400714
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	3.635762054400714
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.635762054400714
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.635762054400714
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	3.635762054400714
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.635762054400714
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.635762054400714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.052685671999999996	3.4479434488728797
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.051573143	3.3751354741120934
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682000000005	3.2749764977075513
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.176504593533358
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.176504593533358
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.046298382	3.029935784254855
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.046298382	3.029935784254855
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0454545	2.9747090536643874
GILLESPIE SYNDROME; GLSP	0.0454545	2.9747090536643874
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.0454545	2.9747090536643874
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0454545	2.9747090536643874
#614782 TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	0.0454545	2.9747090536643874
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.0454545	2.9747090536643874
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0454545	2.9747090536643874
DYSTONIA 27; DYT27	0.0454545	2.9747090536643874
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.0454545	2.9747090536643874
SPINOCEREBELLAR ATAXIA 15	0.0454545	2.9747090536643874
SPINOCEREBELLAR ATAXIA 20	0.0454545	2.9747090536643874
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0454545	2.9747090536643874
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0432581	2.8309685886836164
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7398371077083414
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.7398371077083414
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.684610377117874
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.039939982	2.613818787107826
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4167101916119167
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4167101916119167
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.03646587	2.386460166512635
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.035693192	2.3358932866180746
PHELAN-MCDERMID SYNDROME; PHMDS	0.035177283	2.3021303110454263
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.252419237953158
CORNELIA DE LANGE SYNDROME 1	0.034333401	2.246903580454959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.034314451	2.245663423010329
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.1971925073626903
MENKES DISEASE	0.032494260999999997	2.1265435190978583
MYOCLONIC-ATONIC EPILEPSY	0.032450770000000004	2.1236973086796844
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.032422391999999994	2.1218401483649756
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.03214214	2.1034994304666923
HUNTER-MACDONALD SYNDROME	0.03214214	2.1034994304666923
BRACHYDACTYLY, TYPE A2; BDA2	0.03214214	2.1034994304666923
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.03214214	2.1034994304666923
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.03214214	2.1034994304666923
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.032093532	2.100318344816635
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.03160641	2.068439296017526
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.03160641	2.068439296017526
15q24 recurrent microdeletion syndrome	0.03157851	2.066613417774508
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.03157851	2.066613417774508
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.03157851	2.066613417774508
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	2.0430694704329415
15q13.3 microdeletion syndrome	0.031218750999999996	2.0430694704329415
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.031174782	2.040191977943077
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	2.038366099700059
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9849652473526092
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9849652473526092
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.9831393691095913
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.9831393691095913
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.9831393691095913
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.9831393691095913
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.9831393691095913
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	1.9831393691095913
22q11.2 distal deletion syndrome	0.030302999999999997	1.9831393691095913
CLEFT CHIN	0.030302999999999997	1.9831393691095913
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.9831393691095913
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.9831393691095913
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.9831393691095913
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.9831393691095913
OROFACIAL CLEFT 3	0.030302999999999997	1.9831393691095913
DWARFISM, LEVI TYPE	0.030302999999999997	1.9831393691095913
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.9831393691095913
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.9831393691095913
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.9831393691095913
NASAL BONES, ABSENCE OF	0.030302999999999997	1.9831393691095913
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.9831393691095913
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.9831393691095913
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.9831393691095913
DIMPLES, FACIAL	0.030302999999999997	1.9831393691095913
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.9831393691095913
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.9831393691095913
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.029171203	1.9090704258188242
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02902854	1.8997340362925303
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.027425343	1.7948149494978767
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.7774291201101255
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.7774291201101255
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.7774291201101255
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.7774291201101255
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.026581461	1.739588218907409
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.026581461	1.739588218907409
Myhre syndrome	0.026581461	1.739588218907409
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.026581461	1.739588218907409
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.026581461	1.739588218907409
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.026509592000000002	1.7348848481745265
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.026509592000000002	1.7348848481745265
WARSAW BREAKAGE SYNDROME; WABS	0.026509592000000002	1.7348848481745265
ADAMS-OLIVER SYNDROME 3; AOS3	0.026509592000000002	1.7348848481745265
TOWNES-BROCKS SYNDROME 1; TBS1	0.026509592000000002	1.7348848481745265
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.7222023895196579
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.7222023895196579
MEND SYNDROME; MEND	0.026149833	1.7113409008329596
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.026149833	1.7113409008329596
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.026149833	1.7113409008329596
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.026149833	1.7113409008329596
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.026149833	1.7113409008329596
FEINGOLD SYNDROME 1; FGLDS1	0.02566571	1.679658117584059
PSEUDOTRISOMY 13 SYNDROME	0.02566571	1.679658117584059
MEIER-GORLIN SYNDROME 7	0.025234082	1.65141079950961
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.02500287	1.6362794389245003
Split hand/foot malformation 1 (SHFM1)	0.0243902	1.596184068919142
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.0243902	1.596184068919142
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0243902	1.596184068919142
Mulchandani-Bhoj-Conlin syndrome	0.0243902	1.596184068919142
SYNDACTYLY, TYPE IV; SDTY4	0.0243902	1.596184068919142
%608572 BURN-MCKEOWN SYNDROME	0.0243902	1.596184068919142
#123150 JACKSON-WEISS SYNDROME; JWS;;CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES	0.0243902	1.596184068919142
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0243902	1.596184068919142
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.0243902	1.596184068919142
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0243902	1.596184068919142
CHROMOSOME 2q35 DUPLICATION SYNDROME	0.0243902	1.596184068919142
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.0243902	1.596184068919142
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.024341592000000002	1.5930029832690853
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.024311743	1.5910495553237147
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.024311743	1.5910495553237147
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.5694590359275185
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02349771	1.5377762526786176
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02349771	1.5377762526786176
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.023467861	1.5358228247332473
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.023395992	1.5311194540003648
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.5095289346041683
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.023066082	1.5095289346041683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5095289346041683
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5095289346041683
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.023036233	1.507575506658798
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.023036233	1.507575506658798
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.023036233	1.507575506658798
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.022603852	1.4792789095048866
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.022603852	1.4792789095048866
VERVERI-BRADY SYNDROME; VERBRAS	0.02255211	1.475892723409897
EPILEPSY, HOT WATER, 1	0.0222222	1.4543022040137006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4543022040137006
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4543022040137006
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4543022040137006
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4543022040137006
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4543022040137006
COWDEN SYNDROME 6; CWS6	0.022192351	1.4523487760683302
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.022192351	1.4523487760683302
COWDEN SYNDROME 5; CWS5	0.022192351	1.4523487760683302
GLUTATHIONE SYNTHETASE DEFICIENCY	0.022192351	1.4523487760683302
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.022192351	1.4523487760683302
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.022192351	1.4523487760683302
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.022192351	1.4523487760683302
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.022120482	1.447645405335448
SPINOCEREBELLAR ATAXIA 5; SCA5	0.022120482	1.447645405335448
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.022120482	1.447645405335448
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.022120482	1.447645405335448
PEROXISOME BIOGENESIS DISORDER 6B	0.022120482	1.447645405335448
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.021903043	1.4334154003432087
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.02175997	1.424052178914419
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.021756620999999997	1.4238330080815922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021684752	1.41912963734871
DEMENTIA, FAMILIAL DANISH	0.0212766	1.3924186747449803
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0212766	1.3924186747449803
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0212766	1.3924186747449803
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0212766	1.3924186747449803
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.0212766	1.3924186747449803
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.0212766	1.3924186747449803
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0212766	1.3924186747449803
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0212766	1.3924186747449803
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.0212766	1.3924186747449803
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0212766	1.3924186747449803
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0212766	1.3924186747449803
Boucher-Neuhauser syndrome	0.0212766	1.3924186747449803
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0212766	1.3924186747449803
EPISODIC ATAXIA, TYPE 8	0.0212766	1.3924186747449803
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.0212766	1.3924186747449803
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.0212766	1.3924186747449803
BETA-UREIDOPROPIONASE DEFICIENCY	0.020987292	1.373485299019859
Congenital disorder of glycosylation, type IIh	0.020987292	1.373485299019859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.020987292	1.373485299019859
FUMARASE DEFICIENCY; FMRD	0.020987292	1.373485299019859
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.020987292	1.373485299019859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.020987292	1.373485299019859
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.020987292	1.373485299019859
RING CHROMOSOME 14 SYNDROME	0.020987292	1.373485299019859
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.020987292	1.373485299019859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.020987292	1.373485299019859
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.020987292	1.373485299019859
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.020840869999999997	1.363902906758242
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.020688073	1.3539033111346461
HYPERPROLINEMIA, TYPE I	0.020627533	1.349941351678292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02014341	1.3182585684293913
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02014341	1.3182585684293913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.019711782	1.290011250354942
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.290011250354942
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	1.290011250354942
PEHO-LIKE SYNDROME; PEHOL	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.290011250354942
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.290011250354942
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2347845197644742
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2347845197644742
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2347845197644742
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2347845197644742
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2347845197644742
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2347845197644742
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2347845197644742
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2347845197644742
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	1.2347845197644742
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2347845197644742
CARDIAC ARRHYTHMIA	0.0188679	1.2347845197644742
CERVICAL RIB	0.0188679	1.2347845197644742
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2347845197644742
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2347845197644742
RHEUMATOID ARTHRITIS	0.0188679	1.2347845197644742
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.2347845197644742
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2347845197644742
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2347845197644742
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2347845197644742
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2347845197644742
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	1.2347845197644742
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2347845197644742
TRANSSEXUALITY	0.0188679	1.2347845197644742
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2347845197644742
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2347845197644742
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	1.2347845197644742
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2347845197644742
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.2347845197644742
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2347845197644742
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2347845197644742
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2347845197644742
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2347845197644742
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2347845197644742
ALCOHOL DEPENDENCE	0.0188679	1.2347845197644742
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2347845197644742
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2347845197644742
DIASTEMATOMYELIA	0.0188679	1.2347845197644742
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2347845197644742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2347845197644742
MOTION SICKNESS	0.0188679	1.2347845197644742
269800 SENILE PLAQUE FORMATION	0.0188679	1.2347845197644742
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2347845197644742
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2347845197644742
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2347845197644742
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2347845197644742
ERYTHERMALGIA, PRIMARY	0.0188679	1.2347845197644742
MYOPATHY, CONGENITAL	0.0188679	1.2347845197644742
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2347845197644742
PALMOMENTAL REFLEX	0.0188679	1.2347845197644742
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2347845197644742
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2347845197644742
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2347845197644742
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2347845197644742
THUMBS, CONGENITAL CLASPED	0.0188679	1.2347845197644742
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2347845197644742
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.018660143	1.2211881403331275
COCKAYNE SYNDROME A; CSA	0.018227221000000002	1.1928561381566547
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.018155352	1.188152767423772
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.017795593	1.1646088200822051
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.017744392	1.1612580390097775
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.017744392	1.1612580390097775
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.017744392	1.1612580390097775
MENTAL RETARDATION, X-LINKED 12; MRX12	0.017311470000000002	1.1329260368333045
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.016951711	1.1093820894917377
KUFOR-RAKEB SYNDROME	0.016951711	1.1093820894917377
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.016922053	1.1074411612863106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01690051	1.1060313084193096
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01690051	1.1060313084193096
MICROHYDRANENCEPHALY; MHAC	0.01690051	1.1060313084193096
PAINE SYNDROME	0.01690051	1.1060313084193096
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.016879842	1.1046787187588551
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.016879842	1.1046787187588551
HYPERMANGANESEMIA WITH DYSTONIA 2	0.016879842	1.1046787187588551
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.016825292	1.1011087668536006
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.082487361077743
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.082487361077743
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0777839903448607
ROIFMAN-CHITAYAT SYNDROME	0.016468882	1.0777839903448607
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016468882	1.0777839903448607
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.0777839903448607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	1.0777839903448607
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.0777839903448607
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.0777839903448607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0777839903448607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0777839903448607
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.0777839903448607
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.016035960000000002	1.0494519881683877
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.016035960000000002	1.0494519881683877
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.016035960000000002	1.0494519881683877
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016035960000000002	1.0494519881683877
BEHR SYNDROME	0.016035960000000002	1.0494519881683877
HALLERMANN-STREIFF SYNDROME; HSS	0.015981409999999998	1.045882036263133
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.015981409999999998	1.045882036263133
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	1.022557259754393
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.022557259754393
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.022557259754393
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.022557259754393
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.022557259754393
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.022557259754393
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.022557259754393
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.022557259754393
CARNOSINEMIA	0.015625	1.022557259754393
HYDROXYLYSINURIA	0.015625	1.022557259754393
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.022338088921566
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	1.0176347181886838
PELGER-HUET ANOMALY; PHA	0.015549782	1.0176347181886838
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	1.0176347181886838
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.0176347181886838
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.9624079875982161
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.9624079875982161
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.9624079875982161
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.9624079875982161
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.9624079875982161
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.9624079875982161
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.9624079875982161
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.9624079875982161
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.9624079875982161
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.9624079875982161
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.9624079875982161
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.9624079875982161
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.012936133	0.8465879495870959
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.012936133	0.8465879495870959
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.012936133	0.8465879495870959
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.012092251	0.7913612189966283
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.011660623	0.7631139009221791
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.011660623	0.7631139009221791
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.011660623	0.7631139009221791
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011660623	0.7631139009221791
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.011660623	0.7631139009221791
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.011660623	0.7631139009221791
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0111765	0.7314311176732783
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0111765	0.7314311176732783
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.010816741	0.7078871703317114
TENORIO SYNDROME; TNORS	0.010816741	0.7078871703317114
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.010816741	0.7078871703317114
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.010816741	0.7078871703317114
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.010816741	0.7078871703317114
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.010816741	0.7078871703317114
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.010816741	0.7078871703317114
METACHROMATIC LEUKODYSTROPHY	0.010816741	0.7078871703317114
ALZHEIMER DISEASE 3; AD	0.010816741	0.7078871703317114
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.010816741	0.7078871703317114
CHOREOATHETOSIS, FAMILIAL INVERTED	0.010816741	0.7078871703317114
PETERS-PLUS SYNDROME; PTRPLS	0.010787083000000001	0.7059462421262847
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.010787083	0.7059462421262844
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.010787083	0.7059462421262844
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010787083	0.7059462421262844
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.010787083	0.7059462421262844
CHROMOSOME 16p13.3 DELETION SYNDROME	0.010787083	0.7059462421262844
Glycosylphosphatidylinositol biosynthesis defect 18	0.010787083	0.7059462421262844
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.010787083	0.7059462421262844
HYDROCEPHALUS, NORMAL-PRESSURE	0.010744872	0.703183799598829
COHEN-GIBSON SYNDROME; COGIS	0.010744872	0.703183799598829
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.703183799598829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.703183799598829
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010744872	0.703183799598829
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.703183799598829
JOUBERT SYNDROME 24	0.010744872	0.703183799598829
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.009943201	0.650719511535817
RENPENNING SYNDROME 1; RENS1	0.009943200999999999	0.6507195115358169
BRANCHIOOCULOFACIAL SYNDROME	0.009943200999999999	0.6507195115358169
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.009943200999999999	0.6507195115358169
SECKEL SYNDROME 1; SCKL1	0.009943200999999999	0.6507195115358169
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.6479570690083614
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00990099	0.6479570690083614
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00990099	0.6479570690083614
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.6479570690083614
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.6479570690083614
MELNICK-NEEDLES SYNDROME	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.6479570690083614
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.6479570690083614
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.6479570690083614
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.6479570690083614
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.6479570690083614
MAST SYNDROME	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00990099	0.6479570690083614
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00990099	0.6479570690083614
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.6479570690083614
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.6479570690083614
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.6479570690083614
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00990099	0.6479570690083614
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.6479570690083614
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.6479570690083614
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.6479570690083614
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.6479570690083614
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00990099	0.6479570690083614
MOEBIUS SYNDROME; MBS	0.00990099	0.6479570690083614
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.6479570690083614
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.6479570690083614
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00990099	0.6479570690083614
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.6479570690083614
NEMALINE MYOPATHY 6	0.00990099	0.6479570690083614
BARTH SYNDROME; BTHS	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.6479570690083614
BRITTLE CORNEA SYNDROME 2; BCS2	0.00990099	0.6479570690083614
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.6479570690083614
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00990099	0.6479570690083614
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.6479570690083614
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.6479570690083614
NONAKA MYOPATHY	0.00990099	0.6479570690083614
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.6479570690083614
#156550 KNIEST DYSPLASIA	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.6479570690083614
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.009871332	0.6460161408029345
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009871332	0.6460161408029345
ROIFMAN SYNDROME; RFMN	0.009871332	0.6460161408029345
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.009871332	0.6460161408029345
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009871332	0.6460161408029345
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.009871332	0.6460161408029345
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.009871332	0.6460161408029345
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.009871332	0.6460161408029345
CHROMOSOME 16p13.2 DELETION SYNDROME	0.009511573	0.6224721934613677
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.009511573	0.6224721934613677
CORNELIA DE LANGE SYNDROME 3	0.009511573	0.6224721934613677
RECOMBINANT CHROMOSOME 8 SYNDROME	0.009511573	0.6224721934613677
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.009511573	0.6224721934613677
CATEL-MANZKE SYNDROME; CATMANS	0.009511573	0.6224721934613677
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009511573	0.6224721934613677
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009511573	0.6224721934613677
WIEDEMANN-STEINER SYNDROME; WDSTS	0.009511573	0.6224721934613677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.009511573	0.6224721934613677
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.009511573	0.6224721934613677
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.009511572999999999	0.6224721934613676
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009511572999999999	0.6224721934613676
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.009511572999999999	0.6224721934613676
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009170113	0.6001257997387607
JABERI-ELAHI SYNDROME; JABELS	0.009170113	0.6001257997387607
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009170113	0.6001257997387607
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.009170113	0.6001257997387607
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.009170113	0.6001257997387607
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.009170113	0.6001257997387607
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.009170113	0.6001257997387607
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.009170113	0.6001257997387607
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.009170113	0.6001257997387607
BOWEN-CONRADI SYNDROME	0.00902745	0.5907894102124669
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00902745	0.5907894102124669
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00902745	0.5907894102124669
JOHANSON-BLIZZARD SYNDROME; JBS	0.00902745	0.5907894102124669
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00902745	0.5907894102124669
SECKEL SYNDROME 5; SCKL5	0.00902745	0.5907894102124669
JACOBSEN SYNDROME	0.00902745	0.5907894102124669
3MC SYNDROME 1	0.00902745	0.5907894102124669
DUBOWITZ SYNDROME	0.00902745	0.5907894102124669
MEIER-GORLIN SYNDROME 1; MGORS1	0.00902745	0.5907894102124669
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00902745	0.5907894102124669
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00902745	0.5907894102124669
SECKEL SYNDROME 2; SCKL2	0.00902745	0.5907894102124669
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00902745	0.5907894102124669
BLOOM SYNDROME	0.00902745	0.5907894102124669
MICROCEPHALY-CARDIOMYOPATHY	0.00902745	0.5907894102124669
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00902745	0.5907894102124669
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00902745	0.5907894102124669
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.008667691	0.5672454628709
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008667691	0.5672454628709
PALLISTER-KILLIAN SYNDROME	0.008667691	0.5672454628709
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.008667691	0.5672454628709
OHDO SYNDROME	0.008667691	0.5672454628709
ZUNICH NEUROECTODERMAL SYNDROME	0.008667691	0.5672454628709
WARBURG MICRO SYNDROME 3; WARBM3	0.008667691	0.5672454628709
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.008667691	0.5672454628709
ACROCALLOSAL SYNDROME; ACLS	0.008667691	0.5672454628709
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.008595822	0.5625420921380176
POPOV-CHANG SYNDROME; POPCHAS	0.008595822	0.5625420921380176
CHAR SYNDROME	0.008595822	0.5625420921380176
LARSEN-LIKE SYNDROME	0.008595822	0.5625420921380176
CRANIOFRONTONASAL SYNDROME; CFNS	0.008595822	0.5625420921380176
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.008595822	0.5625420921380176
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.008595822	0.5625420921380176
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.008595822	0.5625420921380176
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008595822	0.5625420921380176
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.008595822	0.5625420921380176
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.008595822	0.5625420921380176
SILVER-RUSSELL SYNDROME; SRS	0.008595822	0.5625420921380176
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.008326231	0.5448990691482931
CHROMOSOME 18Q DELETION SYNDROME	0.008326231	0.5448990691482931
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.008326231	0.5448990691482931
AICARDI-GOUTIERES SYNDROME 6	0.008254362000000001	0.5401956984154107
TONNE-KALSCHEUER SYNDROME; TOKAS	0.008254362000000001	0.5401956984154107
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.007894603	0.5166517510738439
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.007894603	0.5166517510738439
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.007894603	0.5166517510738439
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.007894603	0.5166517510738439
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.007894603	0.5166517510738439
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.007894603	0.5166517510738439
MENTAL RETARDATION, X-LINKED 104; MRX104	0.007894603	0.5166517510738439
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.007894603	0.5166517510738439
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.007894603	0.5166517510738439
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007894603	0.5166517510738439
METHYLMALONIC ACIDURIA, CBLA TYPE	0.007894603	0.5166517510738439
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.007894603	0.5166517510738439
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007894603	0.5166517510738439
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.007894603	0.5166517510738439
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.007894603	0.5166517510738439
BRACHYDACTYLY, TYPE A3	0.00775194	0.50731536154755
NAIL-PATELLA SYNDROME	0.00775194	0.50731536154755
TALONAVICULAR COALITION	0.00775194	0.50731536154755
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00775194	0.50731536154755
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00775194	0.50731536154755
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00775194	0.50731536154755
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00775194	0.50731536154755
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00775194	0.50731536154755
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.00775194	0.50731536154755
TETRALOGY OF FALLOT	0.00775194	0.50731536154755
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00775194	0.50731536154755
PELVIS-SHOULDER DYSPLASIA	0.00775194	0.50731536154755
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00775194	0.50731536154755
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00775194	0.50731536154755
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00775194	0.50731536154755
WILLIAMS-BEUREN SYNDROME; WBS	0.00775194	0.50731536154755
HAND-FOOT-GENITAL SYNDROME; HFG	0.00775194	0.50731536154755
BRACHYDACTYLY, TYPE A1, D	0.00775194	0.50731536154755
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00775194	0.50731536154755
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00775194	0.50731536154755
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.50731536154755
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00775194	0.50731536154755
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00775194	0.50731536154755
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00775194	0.50731536154755
WEYERS ACROFACIAL DYSOSTOSIS	0.00775194	0.50731536154755
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00775194	0.50731536154755
CLEIDORHIZOMELIC SYNDROME	0.00775194	0.50731536154755
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00775194	0.50731536154755
FIBROCHONDROGENESIS 1; FBCG1	0.00775194	0.50731536154755
FLOATING-HARBOR SYNDROME	0.00775194	0.50731536154755
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00775194	0.50731536154755
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00775194	0.50731536154755
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00775194	0.50731536154755
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.00775194	0.50731536154755
WT LIMB-BLOOD SYNDROME	0.00775194	0.50731536154755
SYNPOLYDACTYLY 1	0.00775194	0.50731536154755
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00775194	0.50731536154755
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00775194	0.50731536154755
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00775194	0.50731536154755
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00775194	0.50731536154755
MOLAR I REINCLUSION	0.00775194	0.50731536154755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0074104800000000005	0.484968967824943
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0074104800000000005	0.484968967824943
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0074104800000000005	0.484968967824943
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0074104800000000005	0.484968967824943
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007050721	0.46142502048337625
SNEDDON SYNDROME	0.007050721	0.46142502048337625
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.007050721	0.46142502048337625
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.007050721	0.46142502048337625
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.007050721	0.46142502048337625
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.007050721	0.46142502048337625
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.007050721	0.46142502048337625
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.007050721	0.46142502048337625
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007050721	0.46142502048337625
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.007050721	0.46142502048337625
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.007050721	0.46142502048337625
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.007050721	0.46142502048337625
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.007050721	0.46142502048337625
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.007050721	0.46142502048337625
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.007050721	0.46142502048337625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.007050721	0.46142502048337625
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.007050721	0.46142502048337625
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.007050721	0.46142502048337625
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.007050721	0.46142502048337625
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.006978852	0.45672164975049373
PEROXISOME BIOGENESIS DISORDER 5B	0.006978852	0.45672164975049373
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006978852	0.45672164975049373
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.006978852	0.45672164975049373
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.006978852	0.45672164975049373
GABRIELE-DE VRIES SYNDROME; GADEVS	0.006978852	0.45672164975049373
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006978852	0.45672164975049373
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006978852	0.45672164975049373
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.006978852	0.45672164975049373
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.006978852	0.45672164975049373
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.006978852	0.45672164975049373
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.006978852	0.45672164975049373
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.006978852	0.45672164975049373
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00613497	0.4014949191600261
PERRY SYNDROME	0.00613497	0.4014949191600261
DYSTONIA 13, TORSION	0.00613497	0.4014949191600261
SPASTIC PARAPARESIS AND DEAFNESS	0.00613497	0.4014949191600261
OPTIC ATROPHY 2	0.00613497	0.4014949191600261
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00613497	0.4014949191600261
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00613497	0.4014949191600261
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00613497	0.4014949191600261
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00613497	0.4014949191600261
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00613497	0.4014949191600261
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00613497	0.4014949191600261
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00613497	0.4014949191600261
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.00613497	0.4014949191600261
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00613497	0.4014949191600261
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00613497	0.4014949191600261
#610297 PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00613497	0.4014949191600261
WILSON DISEASE	0.00613497	0.4014949191600261
#176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	0.00613497	0.4014949191600261
MYOPATHY, SPHEROID BODY	0.00613497	0.4014949191600261
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00613497	0.4014949191600261
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00613497	0.4014949191600261
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00613497	0.4014949191600261
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00613497	0.4014949191600261
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00613497	0.4014949191600261
DYSTONIA 11, MYOCLONIC	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00613497	0.4014949191600261
#276880 UROCANASE DEFICIENCY	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA 42	0.00613497	0.4014949191600261
DYSTONIA 3, TORSION, X-LINKED	0.00613497	0.4014949191600261
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00613497	0.4014949191600261
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00613497	0.4014949191600261
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00613497	0.4014949191600261
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00613497	0.4014949191600261
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00613497	0.4014949191600261
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00613497	0.4014949191600261
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00613497	0.4014949191600261
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00613497	0.4014949191600261
CEREBELLAR HYPOPLASIA	0.00613497	0.4014949191600261
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00613497	0.4014949191600261
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00613497	0.4014949191600261
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00613497	0.4014949191600261
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00613497	0.4014949191600261
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00613497	0.4014949191600261
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00613497	0.4014949191600261
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00613497	0.4014949191600261
PARKINSON DISEASE 21; PARK21	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA 18	0.00613497	0.4014949191600261
GLUTATHIONURIA	0.00613497	0.4014949191600261
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00613497	0.4014949191600261
EPISODIC ATAXIA, TYPE 1; EA1	0.00613497	0.4014949191600261
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00613497	0.4014949191600261
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00613497	0.4014949191600261
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00613497	0.4014949191600261
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00613497	0.4014949191600261
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00613497	0.4014949191600261
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0030351430000000006	0.19863088057873463
LISSENCEPHALY 8; LIS8	0.0030351430000000006	0.19863088057873463
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0030351430000000006	0.19863088057873463
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0030351430000000006	0.19863088057873463
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0030351430000000006	0.19863088057873463
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0030351430000000006	0.19863088057873463
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0030351430000000006	0.19863088057873463
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0030351430000000006	0.19863088057873463
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0030351430000000006	0.19863088057873463
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0030351430000000006	0.19863088057873463
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0030351430000000006	0.19863088057873463
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0030351430000000006	0.19863088057873463
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0030351430000000006	0.19863088057873463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0030351430000000006	0.19863088057873463
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030351430000000006	0.19863088057873463
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0030351430000000006	0.19863088057873463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.0030351430000000006	0.19863088057873463
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0030351430000000006	0.19863088057873463
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0030351430000000006	0.19863088057873463
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030351430000000006	0.19863088057873463
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0030351430000000006	0.19863088057873463
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0030351430000000006	0.19863088057873463
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0030351430000000006	0.19863088057873463
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0030351430000000006	0.19863088057873463
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0030351430000000006	0.19863088057873463
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0030351430000000006	0.19863088057873463
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0030351430000000006	0.19863088057873463
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0030351430000000006	0.19863088057873463
KLEEFSTRA SYNDROME 2; KLEFS2	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0030351430000000006	0.19863088057873463
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0030351430000000006	0.19863088057873463
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0030351430000000006	0.19863088057873463
LISSENCEPHALY 4	0.0030351430000000006	0.19863088057873463
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0030351430000000006	0.19863088057873463
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0030351430000000006	0.19863088057873463
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0030351430000000006	0.19863088057873463
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0030351430000000006	0.19863088057873463
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0030351430000000006	0.19863088057873463
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0030351430000000006	0.19863088057873463
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0030351430000000006	0.19863088057873463
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0030351430000000006	0.19863088057873463
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0030351430000000006	0.19863088057873463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0030351430000000006	0.19863088057873463
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0030351430000000006	0.19863088057873463
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0030351430000000006	0.19863088057873463
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0030351430000000006	0.19863088057873463
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0030351430000000006	0.19863088057873463
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0030351430000000006	0.19863088057873463
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0030351430000000006	0.19863088057873463
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0030351430000000006	0.19863088057873463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0030351430000000006	0.19863088057873463
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.0030351430000000006	0.19863088057873463
MACDERMOT-WINTER SYNDROME	0.0030351430000000006	0.19863088057873463
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0030351430000000006	0.19863088057873463
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0030351430000000006	0.19863088057873463
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0030351430000000006	0.19863088057873463
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0030351430000000006	0.19863088057873463
INFANTILE LIVER FAILURE SYNDROME 1	0.0030351430000000006	0.19863088057873463
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0030351430000000006	0.19863088057873463
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0030351430000000006	0.19863088057873463
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0030351430000000006	0.19863088057873463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0030351430000000006	0.19863088057873463
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0030351430000000006	0.19863088057873463
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0030351430000000006	0.19863088057873463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0030351430000000006	0.19863088057873463
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0030351429999999997	0.19863088057873451
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0030351429999999997	0.19863088057873451
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0030351429999999997	0.19863088057873451
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0030351429999999997	0.19863088057873451
BOHRING-OPITZ SYNDROME	0.0030351429999999997	0.19863088057873451
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0030351429999999997	0.19863088057873451
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0030351429999999997	0.19863088057873451
WITTEVEEN-KOLK SYNDROME	0.0030351429999999997	0.19863088057873451
COFFIN-SIRIS SYNDROME 3; CSS3	0.0030351429999999997	0.19863088057873451
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0030351429999999997	0.19863088057873451
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0030351429999999997	0.19863088057873451
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0030351429999999997	0.19863088057873451
CHROMOSOME 19p13.13 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030351429999999997	0.19863088057873451
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0030351429999999997	0.19863088057873451
COFFIN-SIRIS SYNDROME 1; CSS1	0.0030351429999999997	0.19863088057873451
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0030351429999999997	0.19863088057873451
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0030351429999999997	0.19863088057873451
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0030351429999999997	0.19863088057873451
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0030351429999999997	0.19863088057873451
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0030351429999999997	0.19863088057873451
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0030351429999999997	0.19863088057873451
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
POTOCKI-LUPSKI SYNDROME	0.0030351429999999997	0.19863088057873451
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.0030351429999999997	0.19863088057873451
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.0030351429999999997	0.19863088057873451
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0030351429999999997	0.19863088057873451
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0030351429999999997	0.19863088057873451
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0030351429999999997	0.19863088057873451
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0030351429999999997	0.19863088057873451
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0030351429999999997	0.19863088057873451
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0030351429999999997	0.19863088057873451
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0030351429999999997	0.19863088057873451
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.0030351429999999997	0.19863088057873451
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0030351429999999997	0.19863088057873451
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0030351429999999997	0.19863088057873451
ADAMS-OLIVER SYNDROME 1; AOS1	0.0030351429999999997	0.19863088057873451
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0030351429999999997	0.19863088057873451
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0030351429999999997	0.19863088057873451
MEHMO SYNDROME; MEHMO	0.0030351429999999997	0.19863088057873451
COFFIN-SIRIS SYNDROME 4; CSS4	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0030351429999999997	0.19863088057873451
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0030351429999999997	0.19863088057873451
KOOLEN-DE VRIES SYNDROME; KDVS	0.0030351429999999997	0.19863088057873451
ADAMS-OLIVER SYNDROME 2; AOS2	0.0030351429999999997	0.19863088057873451
KBG SYNDROME	0.0030351429999999997	0.19863088057873451
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0030351429999999997	0.19863088057873451
C SYNDROME	0.0030351429999999997	0.19863088057873451
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0030351429999999997	0.19863088057873451
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0030351429999999997	0.19863088057873451
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0030351429999999997	0.19863088057873451
CHROMOSOME 10Q26 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.0030351429999999997	0.19863088057873451
Pierpont syndrome	0.0030351429999999997	0.19863088057873451
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0030351429999999997	0.19863088057873451
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0030351429999999997	0.19863088057873451
VICI SYNDROME; VICIS	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0030351429999999997	0.19863088057873451
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0030351429999999997	0.19863088057873451
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0030351429999999997	0.19863088057873451
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0030351429999999997	0.19863088057873451
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0030351429999999997	0.19863088057873451
COFFIN-SIRIS SYNDROME 5	0.0030351429999999997	0.19863088057873451
HOLOPROSENCEPHALY 1; HPE1	0.0030351429999999997	0.19863088057873451
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0030351429999999997	0.19863088057873451
WIEACKER-WOLFF SYNDROME	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0030351429999999997	0.19863088057873451
KABUKI SYNDROME 1	0.0030351429999999997	0.19863088057873451
GLASS SYNDROME	0.0030351429999999997	0.19863088057873451
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0030351429999999997	0.19863088057873451
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0030351429999999997	0.19863088057873451
EMANUEL SYNDROME	0.0030351429999999997	0.19863088057873451
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0030351429999999997	0.19863088057873451
HOLOPROSENCEPHALY 2; HPE2	0.0030351429999999997	0.19863088057873451
#300867 KABUKI SYNDROME 2; KABUK2	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0030351429999999997	0.19863088057873451
CHROMOSOME 1p35 DELETION SYNDROME	0.0030351429999999997	0.19863088057873451
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0030351429999999997	0.19863088057873451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0030351429999999997	0.19863088057873451
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0030351429999999997	0.19863088057873451
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.0030351429999999997	0.19863088057873451
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0030351429999999997	0.19863088057873451
Xq28 (MECP2) duplication	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0030351429999999997	0.19863088057873451
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0030351429999999997	0.19863088057873451
AL KAISSI SYNDROME; ALKAS	0.0030351429999999997	0.19863088057873451
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0030351429999999997	0.19863088057873451
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0030351429999999997	0.19863088057873451
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0030351429999999997	0.19863088057873451
HEART AND BRAIN MALFORMATION SYNDROME	0.0030351429999999997	0.19863088057873451
ADENYLOSUCCINASE DEFICIENCY	0.0030351429999999997	0.19863088057873451
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.0030351429999999997	0.19863088057873451
AICARDI-GOUTIERES SYNDROME 7	0.0030351429999999997	0.19863088057873451
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0030351429999999997	0.19863088057873451
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.002191261	0.14340414998826692
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.002191261	0.14340414998826692
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002191261	0.14340414998826692
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.002191261	0.14340414998826692
SECKEL SYNDROME 7; SCKL7	0.002191261	0.14340414998826692
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.002191261	0.14340414998826692
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.002191261	0.14340414998826692
ASPARTYLGLUCOSAMINURIA; AGU	0.002191261	0.14340414998826692
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.002191261	0.14340414998826692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002191261	0.14340414998826692
MARDEN-WALKER SYNDROME	0.002191261	0.14340414998826692
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.002191261	0.14340414998826692
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.002191261	0.14340414998826692
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.002191261	0.14340414998826692
FILIPPI SYNDROME; FLPIS	0.002191261	0.14340414998826692
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002191261	0.14340414998826692
OROFACIODIGITAL SYNDROME I; OFD1	0.002191261	0.14340414998826692
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.002191261	0.14340414998826692
COFFIN-LOWRY SYNDROME; CLS	0.002191261	0.14340414998826692
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.002191261	0.14340414998826692
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002191261	0.14340414998826692
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.002191261	0.14340414998826692
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002191261	0.14340414998826692
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.002191261	0.14340414998826692
Angelman syndrome (Type 1)	0.002191261	0.14340414998826692
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002191261	0.14340414998826692
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.002191261	0.14340414998826692
GAUCHER DISEASE, PERINATAL LETHAL	0.002191261	0.14340414998826692
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002191261	0.14340414998826692
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.002191261	0.14340414998826692
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002191261	0.14340414998826692
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.002191261	0.14340414998826692
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002191261	0.14340414998826692
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.002191261	0.14340414998826692
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.002191261	0.14340414998826692
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002191261	0.14340414998826692
XYLOSIDASE DEFICIENCY	0.002191261	0.14340414998826692
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.002191261	0.14340414998826692
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.002191261	0.14340414998826692
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.002191261	0.14340414998826692
KEARNS-SAYRE SYNDROME; KSS	0.002191261	0.14340414998826692
PSEUDO-TORCH SYNDROME 2	0.002191261	0.14340414998826692
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.002191261	0.14340414998826692
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.002191261	0.14340414998826692
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.002191261	0.14340414998826692
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.002191261	0.14340414998826692
LISSENCEPHALY 3; LIS3	0.002191261	0.14340414998826692
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.002191261	0.14340414998826692
MOWAT-WILSON SYNDROME; MOWS	0.002191261	0.14340414998826692
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002191261	0.14340414998826692
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002191261	0.14340414998826692
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.002191261	0.14340414998826692
COHEN SYNDROME	0.002191261	0.14340414998826692
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.002191261	0.14340414998826692
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002191261	0.14340414998826692
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002191261	0.14340414998826692
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002191261	0.14340414998826692
PITT-HOPKINS SYNDROME	0.002191261	0.14340414998826692
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002191261	0.14340414998826692
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.002191261	0.14340414998826692
MICROPHTHALMIA, SYNDROMIC 1	0.002191261	0.14340414998826692
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.002191261	0.14340414998826692
CYCLIC VOMITING SYNDROME	0.002191261	0.14340414998826692
MENTAL RETARDATION, X-LINKED 102	0.002191261	0.14340414998826692
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002191261	0.14340414998826692
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002191261	0.14340414998826692
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.002191261	0.14340414998826692
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002191261	0.14340414998826692
Angelman syndrome (Type 2)	0.002191261	0.14340414998826692
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.002191261	0.14340414998826692
SUPRABULBAR PARESIS, CONGENITAL	0.002191261	0.14340414998826692
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.002191261	0.14340414998826692
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.002191261	0.14340414998826692
PHENYLKETONURIA	0.002191261	0.14340414998826692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002191261	0.14340414998826692
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002191261	0.14340414998826692
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002191261	0.14340414998826692
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.002191261	0.14340414998826692
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.002191261	0.14340414998826692
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002191261	0.14340414998826692
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.002191261	0.14340414998826692
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002191261	0.14340414998826692
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002191261	0.14340414998826692
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.002191261	0.14340414998826692
INCONTINENTIA PIGMENTI; IP	0.002191261	0.14340414998826692
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002191261	0.14340414998826692
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.002191261	0.14340414998826692
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002191261	0.14340414998826692
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002191261	0.14340414998826692
PERRAULT SYNDROME 3	0.002191261	0.14340414998826692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002191261	0.14340414998826692
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002191261	0.14340414998826692
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002191261	0.14340414998826692
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.002191261	0.14340414998826692
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002191261	0.14340414998826692
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.002191261	0.14340414998826692
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.002191261	0.14340414998826692
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002191261	0.14340414998826692
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002191261	0.14340414998826692
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002191261	0.14340414998826692
Wolf-Hirschhorn Syndrome	0.002191261	0.14340414998826692
KLEEFSTRA SYNDROME	0.002191261	0.14340414998826692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002191261	0.14340414998826692
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002191261	0.14340414998826692
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002191261	0.14340414998826692
LATHOSTEROLOSIS	0.002191261	0.14340414998826692
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.002191261	0.14340414998826692
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002191261	0.14340414998826692
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002191261	0.14340414998826692
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0021193920000000003	0.1387007792553845
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0021193920000000003	0.1387007792553845
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.1387007792553845
MARINESCO-SJOGREN SYNDROME; MSS	0.0021193920000000003	0.1387007792553845
MUCOLIPIDOSIS IV; ML4	0.0021193920000000003	0.1387007792553845
ALAZAMI-YUAN SYNDROME	0.0021193920000000003	0.1387007792553845
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.1387007792553845
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0021193920000000003	0.1387007792553845
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021193920000000003	0.1387007792553845
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021193920000000003	0.1387007792553845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0021193920000000003	0.1387007792553845
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.1387007792553845
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.1387007792553845
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.1387007792553845
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0021193920000000003	0.1387007792553845
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0021193920000000003	0.1387007792553845
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021193920000000003	0.1387007792553845
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0021193920000000003	0.1387007792553845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0021193920000000003	0.1387007792553845
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0021193920000000003	0.1387007792553845
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0021193920000000003	0.1387007792553845
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0021193920000000003	0.1387007792553845
GENITOPATELLAR SYNDROME; GTPTS	0.0021193920000000003	0.1387007792553845
BARATELA-SCOTT SYNDROME	0.0021193920000000003	0.1387007792553845
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0021193920000000003	0.1387007792553845
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0021193920000000003	0.1387007792553845
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.1387007792553845
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.1387007792553845
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.1387007792553845
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0021193920000000003	0.1387007792553845
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.1387007792553845
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0021193920000000003	0.1387007792553845
GOLDBERG-SHPRINTZEN SYNDROME	0.0021193920000000003	0.1387007792553845
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0021193920000000003	0.1387007792553845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021193920000000003	0.1387007792553845
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.1387007792553845
MICROPHTHALMIA, SYNDROMIC 3	0.0021193920000000003	0.1387007792553845
TURNPENNY-FRY SYNDROME; TPFS	0.0021193920000000003	0.1387007792553845
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.1387007792553845
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0021193920000000003	0.1387007792553845
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021193920000000003	0.1387007792553845
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0021193920000000003	0.1387007792553845
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0021193920000000003	0.1387007792553845
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.1387007792553845
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021193920000000003	0.1387007792553845
AL-RAQAD SYNDROME; ARS	0.0021193920000000003	0.1387007792553845
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.1387007792553845
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0021193920000000003	0.1387007792553845
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0021193920000000003	0.1387007792553845
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021193920000000003	0.1387007792553845
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0021193920000000003	0.1387007792553845
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0021193920000000003	0.1387007792553845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0021193920000000003	0.1387007792553845
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.1387007792553845
HOLOPROSENCEPHALY 5; HPE5	0.0021193920000000003	0.1387007792553845
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0021193920000000003	0.1387007792553845
LOWRY-MACLEAN SYNDROME	0.0021193920000000003	0.1387007792553845
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021193920000000003	0.1387007792553845
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0021193920000000003	0.1387007792553845
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0021193920000000003	0.1387007792553845
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.1387007792553845
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0021193920000000003	0.1387007792553845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021193920000000003	0.1387007792553845
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0021193920000000003	0.1387007792553845
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0021193920000000003	0.1387007792553845
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.1387007792553845
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.1387007792553845
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0021193920000000003	0.1387007792553845
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.1387007792553845
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0021193920000000003	0.1387007792553845
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.1387007792553845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021193920000000003	0.1387007792553845
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.1387007792553845
OGDEN SYNDROME; OGDNS	0.0021193920000000003	0.1387007792553845
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.1387007792553845
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0021193920000000003	0.1387007792553845
SECKEL SYNDROME 9; SCKL9	0.0021193920000000003	0.1387007792553845
#614728 SECKEL SYNDROME 6; SCKL6	0.0021193920000000003	0.1387007792553845
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021193920000000003	0.1387007792553845
HADZISELIMOVIC SYNDROME	0.0021193920000000003	0.1387007792553845
HOLOPROSENCEPHALY 11	0.0021193920000000003	0.1387007792553845
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.1387007792553845
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0021193920000000003	0.1387007792553845
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.1387007792553845
CEREBELLOFACIODENTAL SYNDROME	0.0021193920000000003	0.1387007792553845
CRANIOSYNOSTOSIS 6; CRS6	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.1387007792553845
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0021193920000000003	0.1387007792553845
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.1387007792553845
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0021193920000000003	0.1387007792553845
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.1387007792553845
OPTIC ATROPHY 11; OPA11	0.0021193920000000003	0.1387007792553845
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.1387007792553845
LIG4 SYNDROME	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0021193920000000003	0.1387007792553845
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0021193920000000003	0.1387007792553845
Mental retardation, autosomal dominant 21	0.0021193920000000003	0.1387007792553845
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021193920000000003	0.1387007792553845
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.1387007792553845
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0021193920000000003	0.1387007792553845
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021193920000000003	0.1387007792553845
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.1387007792553845
OROFACIODIGITAL SYNDROME IX; OFD9	0.0021193920000000003	0.1387007792553845
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0021193920000000003	0.1387007792553845
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0021193920000000003	0.1387007792553845
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021193920000000003	0.1387007792553845
HARTSFIELD SYNDROME; HRTFDS	0.0021193920000000003	0.1387007792553845
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.1387007792553845
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0021193920000000003	0.1387007792553845
RAINE SYNDROME	0.0021193920000000003	0.1387007792553845
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0021193920000000003	0.1387007792553845
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0021193920000000003	0.1387007792553845
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021193920000000003	0.1387007792553845
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.1387007792553845
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.1387007792553845
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.1387007792553845
MEVALONIC ACIDURIA; MEVA	0.0021193920000000003	0.1387007792553845
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021193920000000003	0.1387007792553845
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.11515683191381772
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001759633	0.11515683191381772
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.11515683191381772
PROPIONIC ACIDEMIA	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.11515683191381772
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.11515683191381772
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11515683191381772
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.11515683191381772
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.11515683191381772
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.11515683191381772
WEBB-DATTANI SYNDROME; WEDAS	0.001759633	0.11515683191381772
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.11515683191381772
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001759633	0.11515683191381772
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.11515683191381772
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.11515683191381772
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.11515683191381772
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.11515683191381772
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.11515683191381772
LEIGH SYNDROME; LS	0.001759633	0.11515683191381772
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001759633	0.11515683191381772
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.11515683191381772
Helsmoortel-van der Aa syndrome	0.001759633	0.11515683191381772
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.11515683191381772
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.11515683191381772
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.11515683191381772
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.11515683191381772
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11515683191381772
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.11515683191381772
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.11515683191381772
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001759633	0.11515683191381772
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11515683191381772
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001759633	0.11515683191381772
TIMOTHY SYNDROME; TS	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001759633	0.11515683191381772
BAND HETEROTOPIA; BH	0.001759633	0.11515683191381772
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.11515683191381772
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.11515683191381772
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001759633	0.11515683191381772
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.11515683191381772
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.11515683191381772
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.11515683191381772
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001759633	0.11515683191381772
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.11515683191381772
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.11515683191381772
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.11515683191381772
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.11515683191381772
LISSENCEPHALY 1; LIS1	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.11515683191381772
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.11515683191381772
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.11515683191381772
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.11515683191381772
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001759633	0.11515683191381772
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.11515683191381772
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001759633	0.11515683191381772
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.11515683191381772
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.11515683191381772
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001759633	0.11515683191381772
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.11515683191381772
COFFIN-SIRIS SYNDROME 2; CSS2	0.001759633	0.11515683191381772
PEHO SYNDROME; PEHO	0.001759633	0.11515683191381772
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11515683191381772
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.11515683191381772
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001759633	0.11515683191381772
PHACE ASSOCIATION	0.001759633	0.11515683191381772
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.11515683191381772
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.11515683191381772
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.11515683191381772
SCHAAF-YANG SYNDROME; SHFYNG	0.001759633	0.11515683191381772
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11515683191381772
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.11515683191381772
XQ25 DUPLICATION SYNDROME	0.001759633	0.11515683191381772
SALLA DISEASE	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.11515683191381772
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.11515683191381772
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.11515683191381772
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.11515683191381772
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.11515683191381772
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.11515683191381772
Cerebral creatine deficiency syndrome 2	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.11515683191381772
CODAS SYNDROME	0.001759633	0.11515683191381772
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.11515683191381772
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.11515683191381772
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.11515683191381772
Muenke syndrome	0.001759633	0.11515683191381772
PETTIGREW SYNDROME	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001759633	0.11515683191381772
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11515683191381772
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11515683191381772
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11515683191381772
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.11515683191381772
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.11515683191381772
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.11515683191381772
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 7	0.001759633	0.11515683191381772
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.11515683191381772
SULFOCYSTEINURIA	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.11515683191381772
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.11515683191381772
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.11515683191381772
ELEJALDE DISEASE	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.11515683191381772
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.11515683191381772
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.11515683191381772
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.11515683191381772
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001759633	0.11515683191381772
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.11515683191381772
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.11515683191381772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.11515683191381772
PALLISTER-HALL SYNDROME	0.001759633	0.11515683191381772
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.11515683191381772
PRADER-WILLI SYNDROME; PWS	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.11515683191381772
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001759633	0.11515683191381772
TEMTAMY SYNDROME; TEMTYS	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11515683191381772
SCHINDLER DISEASE, TYPE I	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11515683191381772
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001759633	0.11515683191381772
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11515683191381772
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.11515683191381772
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001759633	0.11515683191381772
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.11515683191381772
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.11515683191381772
LANDAU-KLEFFNER SYNDROME	0.001759633	0.11515683191381772
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.11515683191381772
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.11515683191381772
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.11515683191381772
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001759633	0.11515683191381772
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001759633	0.11515683191381772
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.11515683191381772
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.11515683191381772
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.11515683191381772
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.11515683191381772
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.11515683191381772
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.11515683191381772
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001759633	0.11515683191381772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.11515683191381772
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.11515683191381772
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.11515683191381772
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11515683191381772
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.11515683191381772
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.11515683191381772
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.11515683191381772
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001759633	0.11515683191381772
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001759633	0.11515683191381772
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.11515683191381772
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.11515683191381772
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001759633	0.11515683191381772
MIRAGE SYNDROME; MIRAGE	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.11515683191381772
DESANTO-SHINAWI SYNDROME	0.001759633	0.11515683191381772
DIGEORGE SYNDROME; DGS	0.001759633	0.11515683191381772
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.11515683191381772
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.11515683191381772
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001759633	0.11515683191381772
CITRULLINEMIA, CLASSIC	0.001759633	0.11515683191381772
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11515683191381772
INFANTILE SIALIC ACID STORAGE DISEASE	0.001759633	0.11515683191381772
COACH SYNDROME	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.11515683191381772
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11515683191381772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.11515683191381772
HARTNUP DISORDER	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11515683191381772
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001759633	0.11515683191381772
611961 STEVENSON-CAREY SYNDROME	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.11515683191381772
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001759633	0.11515683191381772
GAUCHER DISEASE, TYPE II	0.001759633	0.11515683191381772
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.11515683191381772
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.11515683191381772
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.11515683191381772
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11515683191381772
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.11515683191381772
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.11515683191381772
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.11515683191381772
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.11515683191381772
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.11515683191381772
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.11515683191381772
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.11515683191381772
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.11515683191381772
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001759633	0.11515683191381772
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001759633	0.11515683191381772
SMITH-MAGENIS SYNDROME; SMS	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001759633	0.11515683191381772
ZTTK SYNDROME; ZTTKS	0.001759633	0.11515683191381772
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.11515683191381772
KETOADIPICACIDURIA	0.001759633	0.11515683191381772
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.11515683191381772
WEAVER SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.11515683191381772
KAGAMI-OGATA SYNDROME	0.001759633	0.11515683191381772
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11515683191381772
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.11515683191381772
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.11515683191381772
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.08347404866491685
COFFIN-SIRIS SYNDROME 10; CSS10	0.00127551	0.08347404866491685
RUVALCABA SYNDROME	0.00127551	0.08347404866491685
CRI-DU-CHAT SYNDROME	0.00127551	0.08347404866491685
Miller-Dieker syndrome (MDS)	0.00127551	0.08347404866491685
BARDET-BIEDL SYNDROME 20	0.00127551	0.08347404866491685
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00127551	0.08347404866491685
VELOCARDIOFACIAL SYNDROME	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.08347404866491685
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00127551	0.08347404866491685
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00127551	0.08347404866491685
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.08347404866491685
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.08347404866491685
HYPERREFLEXIA	0.00127551	0.08347404866491685
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.08347404866491685
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.08347404866491685
#278250 WRINKLY SKIN SYNDROME; WSS	0.00127551	0.08347404866491685
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.08347404866491685
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00127551	0.08347404866491685
YUNIS-VARON SYNDROME	0.00127551	0.08347404866491685
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.08347404866491685
MASA SYNDROME	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.08347404866491685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00127551	0.08347404866491685
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.08347404866491685
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.08347404866491685
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.08347404866491685
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.08347404866491685
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00127551	0.08347404866491685
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.08347404866491685
MECKEL SYNDROME, TYPE 1; MKS1	0.00127551	0.08347404866491685
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.08347404866491685
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.08347404866491685
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.08347404866491685
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.08347404866491685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.08347404866491685
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00127551	0.08347404866491685
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.08347404866491685
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.08347404866491685
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.08347404866491685
2p15-16.1 microdeletion syndrome	0.00127551	0.08347404866491685
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00127551	0.08347404866491685
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.08347404866491685
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00127551	0.08347404866491685
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.08347404866491685
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.08347404866491685
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.08347404866491685
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.08347404866491685
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.08347404866491685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.08347404866491685
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.08347404866491685
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00127551	0.08347404866491685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00127551	0.08347404866491685
9q subtelomeric deletion syndrome	0.00127551	0.08347404866491685
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.08347404866491685
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.08347404866491685
RHIZOMELIC SYNDROME	0.00127551	0.08347404866491685
MEIER-GORLIN SYNDROME 6; MGORS6	0.00127551	0.08347404866491685
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.08347404866491685
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.08347404866491685
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.08347404866491685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00127551	0.08347404866491685
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00127551	0.08347404866491685
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.08347404866491685
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.08347404866491685
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00127551	0.08347404866491685
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00127551	0.08347404866491685
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.08347404866491685
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00127551	0.08347404866491685
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00127551	0.08347404866491685
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.08347404866491685
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00127551	0.08347404866491685
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.08347404866491685
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.08347404866491685
FACIOCARDIOMELIC SYNDROME	0.00127551	0.08347404866491685
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.08347404866491685
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.08347404866491685
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.08347404866491685
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.08347404866491685
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.08347404866491685
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00127551	0.08347404866491685
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00127551	0.08347404866491685
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.08347404866491685
FONTAINE PROGEROID SYNDROME; FPS	0.00127551	0.08347404866491685
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.08347404866491685
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00127551	0.08347404866491685
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.08347404866491685
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.08347404866491685
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.08347404866491685
MARTSOLF SYNDROME	0.00127551	0.08347404866491685
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00127551	0.08347404866491685
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.08347404866491685
ADDUCTED THUMBS SYNDROME	0.00127551	0.08347404866491685
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.08347404866491685
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00127551	0.08347404866491685
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.08347404866491685
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.08347404866491685
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.08347404866491685
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.08347404866491685
MECKEL SYNDROME, TYPE 4; MKS4	0.00127551	0.08347404866491685
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.08347404866491685
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00127551	0.08347404866491685
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00127551	0.08347404866491685
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.08347404866491685
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.08347404866491685
#256520 NEU-LAXOVA SYNDROME; NLS	0.00127551	0.08347404866491685
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.08347404866491685
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00127551	0.08347404866491685
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.08347404866491685
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.08347404866491685
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00127551	0.08347404866491685
GERODERMA OSTEODYSPLASTICUM; GO	0.00127551	0.08347404866491685
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.08347404866491685
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.08347404866491685
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.08347404866491685
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.08347404866491685
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00127551	0.08347404866491685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00127551	0.08347404866491685
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.08347404866491685
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.08347404866491685
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00127551	0.08347404866491685
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.08347404866491685
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00127551	0.08347404866491685
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.08347404866491685
CHARGE SYNDROME	0.00127551	0.08347404866491685
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.08347404866491685
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.08347404866491685
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.08347404866491685
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.08347404866491685
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.08347404866491685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.08347404866491685
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.08347404866491685
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.08347404866491685
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00127551	0.08347404866491685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00127551	0.08347404866491685
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.08347404866491685
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.08347404866491685
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.08347404866491685
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.08347404866491685
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.08347404866491685
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.08347404866491685
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.08347404866491685
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00127551	0.08347404866491685
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00127551	0.08347404866491685
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.08347404866491685
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.08347404866491685
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.08347404866491685
Cri du Chat Syndrome (5p deletion)	0.00127551	0.08347404866491685
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.08347404866491685
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.08347404866491685
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.08347404866491685
Diamond-Blackfan anemia 1	0.00127551	0.08347404866491685
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.08347404866491685
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.08347404866491685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.08347404866491685
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00127551	0.08347404866491685
MECKEL SYNDROME 12; MKS12	0.00127551	0.08347404866491685
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.08347404866491685
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.08347404866491685
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.08347404866491685
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.08347404866491685
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.08347404866491685
LAMBOTTE SYNDROME	0.00127551	0.08347404866491685
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.08347404866491685
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.08347404866491685
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.08347404866491685
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.08347404866491685
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.08347404866491685
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00127551	0.08347404866491685
FOCAL DERMAL HYPOPLASIA; FDH	0.00127551	0.08347404866491685
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.08347404866491685
TEEBI-SHALTOUT SYNDROME; TBSH	0.00127551	0.08347404866491685
ALLAN-HERNDON-DUDLEY SYNDROME	0.00127551	0.08347404866491685
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00127551	0.08347404866491685
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.08347404866491685
SECKEL SYNDROME 10; SCKL10	0.00127551	0.08347404866491685
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00127551	0.08347404866491685
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00127551	0.08347404866491685
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.08347404866491685
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.08347404866491685
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.08347404866491685
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00127551	0.08347404866491685
XFE PROGEROID SYNDROME; XFEPS	0.00127551	0.08347404866491685
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.08347404866491685
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.08347404866491685
SECKEL SYNDROME 4	0.00127551	0.08347404866491685
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.08347404866491685
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00127551	0.08347404866491685
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.08347404866491685
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00127551	0.08347404866491685
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.08347404866491685
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.08347404866491685
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.08347404866491685
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.08347404866491685
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.08347404866491685
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.08347404866491685
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.08347404866491685
WARBURG MICRO SYNDROME 1	0.00127551	0.08347404866491685
STROMME SYNDROME; STROMS	0.00127551	0.08347404866491685
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00127551	0.08347404866491685
FANCONI ANEMIA	0.00127551	0.08347404866491685
SAY SYNDROME	0.00127551	0.08347404866491685
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.08347404866491685
ROBERTS SYNDROME; RBS	0.00127551	0.08347404866491685
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.08347404866491685
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.08347404866491685
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.08347404866491685
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00127551	0.08347404866491685
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.05993010132335009
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.05993010132335009
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.05993010132335009
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.05993010132335009
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.05993010132335009
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.05993010132335009
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.05993010132335009
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.05993010132335009
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.05993010132335009
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.05993010132335009
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.05993010132335009
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.05993010132335009
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.05993010132335009
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.05993010132335009
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.05993010132335009
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.05993010132335009
LISSENCEPHALY 5; LIS5	0.000915751	0.05993010132335009
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.05993010132335009
PARIETAL FORAMINA	0.000915751	0.05993010132335009
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.05993010132335009
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.05993010132335009
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.05993010132335009
KRABBE DISEASE	0.000915751	0.05993010132335009
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.05993010132335009
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.05993010132335009
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.05993010132335009
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.05993010132335009
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.05993010132335009
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.05993010132335009
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.05993010132335009
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.05993010132335009
RAMON SYNDROME	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.05993010132335009
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.05993010132335009
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.05993010132335009
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.05993010132335009
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.05993010132335009
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.05993010132335009
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.05993010132335009
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.05993010132335009
Adrenoleukodystrophy	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.05993010132335009
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.05993010132335009
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.05993010132335009
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.05993010132335009
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.05993010132335009
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.05993010132335009
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.05993010132335009
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.05993010132335009
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.05993010132335009
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.05993010132335009
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.05993010132335009
EPISODIC ATAXIA, TYPE 6	0.000915751	0.05993010132335009
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.05993010132335009
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.05993010132335009
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.05993010132335009
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.05993010132335009
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.05993010132335009
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.05993010132335009
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.05993010132335009
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.05993010132335009
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 47	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.05993010132335009
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.05993010132335009
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.05993010132335009
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.05993010132335009
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.05993010132335009
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.05993010132335009
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.05993010132335009
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.05993010132335009
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.05993010132335009
LOWE OCULOCEREBRORENAL SYNDROME	0.000915751	0.05993010132335009
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.05993010132335009
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.05993010132335009
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY	0.000915751	0.05993010132335009
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.05993010132335009
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.05993010132335009
POTOCKI-SHAFFER SYNDROME	0.000915751	0.05993010132335009
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.05993010132335009
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.05993010132335009
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.05993010132335009
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.05993010132335009
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.05993010132335009
TAY-SACHS DISEASE; TSD	0.000915751	0.05993010132335009
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.05993010132335009
THYROCEREBRORETINAL SYNDROME	0.000915751	0.05993010132335009
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.05993010132335009
GURRIERI SYNDROME	0.000915751	0.05993010132335009
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000915751	0.05993010132335009
THREONINEMIA	0.000915751	0.05993010132335009
CRANIOSYNOSTOSIS 2	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.05993010132335009
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000915751	0.05993010132335009
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.05993010132335009
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.05993010132335009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.000915751	0.05993010132335009
FRYNS SYNDROME; FRNS	0.000915751	0.05993010132335009
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.05993010132335009
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.05993010132335009
FLYNN-AIRD SYNDROME	0.000915751	0.05993010132335009
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.05993010132335009
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.05993010132335009
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.05993010132335009
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.05993010132335009
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.05993010132335009
HYPERPROLINEMIA, TYPE II	0.000915751	0.05993010132335009
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.05993010132335009
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.05993010132335009
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.05993010132335009
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.05993010132335009
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.05993010132335009
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.05993010132335009
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.05993010132335009
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.05993010132335009
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.05993010132335009
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.05993010132335009
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.05993010132335009
RETT SYNDROME; RTT	0.000915751	0.05993010132335009
HYPERLYSINEMIA, TYPE I	0.000915751	0.05993010132335009
KIFAFA SEIZURE DISORDER	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.05993010132335009
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.05993010132335009
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.05993010132335009
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.05993010132335009
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.05993010132335009
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.05993010132335009
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.05993010132335009
STURGE-WEBER SYNDROME	0.000915751	0.05993010132335009
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.05993010132335009
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.05993010132335009
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.05993010132335009
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.05993010132335009
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.05993010132335009
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.05993010132335009
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.05993010132335009
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.05993010132335009
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.05993010132335009
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.05993010132335009
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.05993010132335009
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.05993010132335009
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.05993010132335009
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.05993010132335009
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.05993010132335009
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.05993010132335009
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.05993010132335009
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.05993010132335009
GAPO SYNDROME; GAPOS	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.05993010132335009
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.05993010132335009
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.05993010132335009
ALEXANDER DISEASE	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.05993010132335009
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.05993010132335009
GITELMAN SYNDROME	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.05993010132335009
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.05993010132335009
AUTISM	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.05993010132335009
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.05993010132335009
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.05993010132335009
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.05993010132335009
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.05993010132335009
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.05993010132335009
ATKIN-FLAITZ SYNDROME	0.000915751	0.05993010132335009
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.05993010132335009
DIAMINOPENTANURIA	0.000915751	0.05993010132335009
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.05993010132335009
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.05993010132335009
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.05993010132335009
SMITH-KINGSMORE SYNDROME; SKS	0.000915751	0.05993010132335009
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.05993010132335009
HHHH SYNDROME	0.000915751	0.05993010132335009
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.05993010132335009
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.05993010132335009
HYPER-BETA-ALANINEMIA	0.000915751	0.05993010132335009
EPILEPSY-TELANGIECTASIA	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.05993010132335009
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.05993010132335009
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.05993010132335009
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.05993010132335009
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.05993010132335009
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.05993010132335009
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.05993010132335009
HUNTINGTON DISEASE; HD	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.05993010132335009
PAPILLORENAL SYNDROME	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.05993010132335009
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.05993010132335009
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.05993010132335009
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.05993010132335009
CROUZON SYNDROME	0.000915751	0.05993010132335009
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.05993010132335009
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.05993010132335009
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.05993010132335009
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.05993010132335009
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.05993010132335009
EPILEPSY, READING	0.000915751	0.05993010132335009
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.05993010132335009
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.05993010132335009
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.05993010132335009
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.05993010132335009
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000915751	0.05993010132335009
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.05993010132335009
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.05993010132335009
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.05993010132335009
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.05993010132335009
KAPUR-TORIELLO SYNDROME	0.000915751	0.05993010132335009
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.05993010132335009
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.05993010132335009
CLARK-BARAITSER SYNDROME	0.000915751	0.05993010132335009
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.05993010132335009
KEUTEL SYNDROME; KTLS	0.000915751	0.05993010132335009
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.05993010132335009
CROME SYNDROME	0.000915751	0.05993010132335009
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.05993010132335009
2q33.1 deletion syndrome	0.000915751	0.05993010132335009
NOONAN SYNDROME 7; NS7	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.05993010132335009
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.05993010132335009
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.05993010132335009
DARIER-WHITE DISEASE; DAR	0.000915751	0.05993010132335009
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.05993010132335009
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.05993010132335009
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.05993010132335009
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.05993010132335009
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.05993010132335009
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.05993010132335009
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.05993010132335009
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.05993010132335009
Fabry disease	0.000915751	0.05993010132335009
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.05993010132335009
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.05993010132335009
DYSOSTEOSCLEROSIS	0.000915751	0.05993010132335009
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.05993010132335009
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.05993010132335009
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.05993010132335009
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.05993010132335009
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000915751	0.05993010132335009
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.05993010132335009
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.05993010132335009
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.05993010132335009
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.05993010132335009
1p36 microdeletion syndrome	0.000915751	0.05993010132335009
FOUNTAIN SYNDROME	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.05993010132335009
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.05993010132335009
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.05993010132335009
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.05993010132335009
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.05993010132335009
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.05993010132335009
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.05522673059046762
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.05522673059046762
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.05522673059046762
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.05522673059046762
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.05522673059046762
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.05522673059046762
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.05522673059046762
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.05522673059046762
CURRY-JONES SYNDROME	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.05522673059046762
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.05522673059046762
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000843882	0.05522673059046762
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.05522673059046762
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.05522673059046762
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.05522673059046762
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.05522673059046762
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.05522673059046762
FRONTOOCULAR SYNDROME	0.000843882	0.05522673059046762
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.05522673059046762
NOONAN SYNDROME 11; NS11	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.05522673059046762
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.05522673059046762
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.05522673059046762
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.05522673059046762
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.05522673059046762
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.05522673059046762
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.05522673059046762
Bardet-Biedl syndrome 2	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.05522673059046762
OROTIC ACIDURIA	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.05522673059046762
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.05522673059046762
CDAGS SYNDROME	0.000843882	0.05522673059046762
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.05522673059046762
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.05522673059046762
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.05522673059046762
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.05522673059046762
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.05522673059046762
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.05522673059046762
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 26	0.000843882	0.05522673059046762
ARIMA SYNDROME	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.05522673059046762
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.05522673059046762
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.05522673059046762
JOUBERT SYNDROME 6	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.05522673059046762
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.05522673059046762
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.05522673059046762
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.05522673059046762
NAVAJO NEUROHEPATOPATHY	0.000843882	0.05522673059046762
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.05522673059046762
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.05522673059046762
TARP SYNDROME; TARPS	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.05522673059046762
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.05522673059046762
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.05522673059046762
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.05522673059046762
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.05522673059046762
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.05522673059046762
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.05522673059046762
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.05522673059046762
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.05522673059046762
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.05522673059046762
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.05522673059046762
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.05522673059046762
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000843882	0.05522673059046762
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.05522673059046762
SEPTOOPTIC DYSPLASIA	0.000843882	0.05522673059046762
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.05522673059046762
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.05522673059046762
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.05522673059046762
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.05522673059046762
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.05522673059046762
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.05522673059046762
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.05522673059046762
HURLER SYNDROME	0.000843882	0.05522673059046762
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.05522673059046762
CULLER-JONES SYNDROME; CJS	0.000843882	0.05522673059046762
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.05522673059046762
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.05522673059046762
3MC SYNDROME 2	0.000843882	0.05522673059046762
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.05522673059046762
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.05522673059046762
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.000843882	0.05522673059046762
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.05522673059046762
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000843882	0.05522673059046762
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.05522673059046762
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.05522673059046762
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.05522673059046762
COSTELLO SYNDROME; CSTLO	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.05522673059046762
NETHERTON SYNDROME; NETH	0.000843882	0.05522673059046762
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.05522673059046762
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.05522673059046762
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000843882	0.05522673059046762
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.05522673059046762
LAMB-SHAFFER SYNDROME	0.000843882	0.05522673059046762
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.05522673059046762
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.05522673059046762
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.05522673059046762
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.05522673059046762
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.05522673059046762
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.05522673059046762
JOUBERT SYNDROME 14	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.05522673059046762
JOUBERT SYNDROME 8	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.05522673059046762
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.05522673059046762
COFFIN-SIRIS SYNDROME 6; CSS6	0.000843882	0.05522673059046762
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.05522673059046762
COFFIN-SIRIS SYNDROME 7; CSS7	0.000843882	0.05522673059046762
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.05522673059046762
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME VI	0.000843882	0.05522673059046762
NOONAN SYNDROME 9; NS9	0.000843882	0.05522673059046762
JOUBERT SYNDROME 1	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.05522673059046762
HYDROXYKYNURENINURIA	0.000843882	0.05522673059046762
WAARDENBURG-SHAH SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 28	0.000843882	0.05522673059046762
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.05522673059046762
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.05522673059046762
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000843882	0.05522673059046762
EVEN-PLUS SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 7	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.05522673059046762
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.05522673059046762
CHOPS SYNDROME; CHOPS	0.000843882	0.05522673059046762
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.05522673059046762
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.05522673059046762
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.05522673059046762
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.05522673059046762
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.05522673059046762
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.05522673059046762
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.05522673059046762
JOUBERT SYNDROME 15	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.05522673059046762
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.05522673059046762
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.05522673059046762
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.05522673059046762
NOONAN SYNDROME 2; NS2	0.000843882	0.05522673059046762
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.05522673059046762
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.05522673059046762
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.05522673059046762
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.05522673059046762
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.05522673059046762
REVESZ SYNDROME	0.000843882	0.05522673059046762
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.05522673059046762
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 2	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.05522673059046762
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.05522673059046762
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.05522673059046762
JOUBERT SYNDROME 21	0.000843882	0.05522673059046762
Temtamy preaxial brachydactyly syndrome	0.000843882	0.05522673059046762
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.05522673059046762
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.05522673059046762
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.05522673059046762
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000843882	0.05522673059046762
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.05522673059046762
AUSTRALIA ANTIGEN	0.000843882	0.05522673059046762
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.05522673059046762
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.05522673059046762
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.05522673059046762
Aarskog-Scott syndrome	0.000843882	0.05522673059046762
NOONAN SYNDROME 5; NS5	0.000843882	0.05522673059046762
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.05522673059046762
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.05522673059046762
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.05522673059046762
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.05522673059046762
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.05522673059046762
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.05522673059046762
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.05522673059046762
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.05522673059046762
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.05522673059046762
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.05522673059046762
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.05522673059046762
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.05522673059046762
#170100 PROLIDASE DEFICIENCY	0.000843882	0.05522673059046762
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.05522673059046762
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.05522673059046762
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.05522673059046762
CURRARINO SYNDROME	0.000843882	0.05522673059046762
AU-KLINE SYNDROME; AUKS	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 1; BBS1	0.000843882	0.05522673059046762
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.05522673059046762
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.05522673059046762
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.05522673059046762
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.05522673059046762
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.05522673059046762
RAHMAN SYNDROME	0.000843882	0.05522673059046762
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.05522673059046762
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.05522673059046762
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.05522673059046762
NOONAN SYNDROME 6; NS6	0.000843882	0.05522673059046762
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.05522673059046762
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.000843882	0.05522673059046762
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.05522673059046762
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.05522673059046762
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.05522673059046762
STEEL SYNDROME; STLS	0.000843882	0.05522673059046762
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.05522673059046762
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.05522673059046762
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.05522673059046762
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.05522673059046762
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.05522673059046762
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.05522673059046762
JOUBERT SYNDROME 25	0.000843882	0.05522673059046762
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
NOONAN SYNDROME 3; NS3	0.000843882	0.05522673059046762
300270 ADRENOMYODYSTROPHY	0.000843882	0.05522673059046762
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.05522673059046762
FRIAS SYNDROME	0.000843882	0.05522673059046762
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.05522673059046762
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.05522673059046762
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.05522673059046762
XIA-GIBBS SYNDROME	0.000843882	0.05522673059046762
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.05522673059046762
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.05522673059046762
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.05522673059046762
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.05522673059046762
JOUBERT SYNDROME 10	0.000843882	0.05522673059046762
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.05522673059046762
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.05522673059046762
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.05522673059046762
Jawad syndrome	0.000843882	0.05522673059046762
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.05522673059046762
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.05522673059046762
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.05522673059046762
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.05522673059046762
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.05522673059046762
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.05522673059046762
#300555 DENT DISEASE 2	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.05522673059046762
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.05522673059046762
SENIOR-LOKEN SYNDROME 9	0.000843882	0.05522673059046762
TYSHCHENKO SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 27	0.000843882	0.05522673059046762
Cerebral creatine deficiency syndrome 3	0.000843882	0.05522673059046762
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.05522673059046762
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.05522673059046762
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.05522673059046762
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.05522673059046762
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.05522673059046762
ALSTROM SYNDROME; ALMS	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.05522673059046762
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.05522673059046762
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.05522673059046762
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.05522673059046762
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.05522673059046762
MECKEL SYNDROME 13; MKS13	0.000843882	0.05522673059046762
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.05522673059046762
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.05522673059046762
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.05522673059046762
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.05522673059046762
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.05522673059046762
PELLAGRA-LIKE SYNDROME	0.000843882	0.05522673059046762
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.05522673059046762
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.05522673059046762
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.05522673059046762
